320 records found.
Nov 15, 2019
New Novartis medicine Adakveo® (crizanlizumab-tmca) approved by FDA to reduce frequency of pain crises in individuals living with sickle cell disease
Nov 15, 2019
FDA approves first targeted therapy to treat patients with painful complication of sickle cell disease
Nov 13, 2019
Family Of USAF Soldier With Leukemia Widens Search For Bone Marrow Match
Nov 07, 2019
Partner Therapeutics (PTx) Announces the Appointment of John McManus as Chief Business Officer
Nov 07, 2019
Cold Agglutinin Disease (CAD) Epidemiology Report 2019: Total Prevalent Cases the 10EM was Found to be 29,077 in 2017 - Forecast to 2028
Nov 06, 2019
Sierra Oncology to Report New Analyses Supporting Momelotinib's Anemia Benefits at ASH 2019
Nov 06, 2019
Actinium Announces Interim Results from Phase 1 Actimab-A CLAG-M Combination Trial in Patients with Relapsed or Refractory AML Accepted for Presentation at ASH 2019
Nov 06, 2019
New data to be presented at ASH 2019 highlight Sanofi's commitment to treat challenging blood cancers and rare blood disorders
Oct 31, 2019
Mallinckrodt Announces UVADEX® (Methoxsalen) Approved in Australia for use with the THERAKOS® CELLEX® Photopheresis System for Treatment of Chronic Graft Versus Host Disease (cGvHD) and Skin Manifestations of Cutaneous T-Cell Lymphoma (CTCL) in Adults
Oct 29, 2019
Disc Medicine Completes $50 Million Series A Financing led by Novo Holdings A/S to Advance New Therapies Addressing Ineffective Red Blood Cell Production
Oct 29, 2019
Disc Medicine Expands Pipeline Focused on Hepcidin Pathway
Oct 24, 2019
Hemanext Announces Publication of Data Demonstrating Significant Benefits Following the Transfusion of Hypoxically Stored Red Blood Cells
Oct 21, 2019
The Australian Red Cross Blood Service Selects Abbott's Alinity s Solution for Blood and Plasma Screening
Oct 19, 2019
Biolog-id LLC to Showcase Latest Innovations in Blood Supply Management at the 2019 AABB Annual Meeting
Oct 14, 2019
Further restricting blood transfusions guidelines could save lives and money
Oct 10, 2019
FDA Clears GEKO DEVICE for Use in Non-surgical Patients at Risk for Deep Vein Thrombosis Based on Study Demonstrating a Zero Percent DVT Rate in Patients After a Stroke
Oct 09, 2019
Society for the Advancement of Blood Management Selects Talley Management Group, Inc. as AMC
Oct 09, 2019
Ionis' Factor XI anti-thrombotic medicine advances with Bayer following positive clinical results
Oct 09, 2019
World Thrombosis Day Empowers People Around the World to Recognize and Help Prevent Life-Threatening Blood Clots
Oct 03, 2019
Hemanext to Present Extensive, Significant Red Blood Cell Data at AABB 2019

Pages